Othon Gervasio Email & Phone Number

Australia

Australia

Australia

- Member of the Country Executive Oncology Leadership team, designing the vision, developing 5-year strategy, and establishing culture- Leader of the Solid Tumours, Haematology and Cell & Gene Medical Affairs teams, including Investigator Initiated Trials, Phase IV studies/registries, Compassionate Programs, with oversight of over 15 disease states- Strength-based coaching and development, fostering a culture of empowerment, engagement, psychological safety, measured risk-taking and integrity - Finance and budget responsibilities, resource allocation, recruitment, retention and development of talents, RWE studies supporting regulatory submissions, executive approval of SOPs, grants review/approval, protocol approvals in ANZ, APAC, Middle East and Africa- Data and digital strategy oversight, insights generation, omnichannel, leading to the optimisation of systems, processes and customer experience in medical affairs- Oversight of Statistical Analysis Plans (inferential/descriptive statistics) and database implementations (validation/deployment) for analysis of clinical information- Launch of several brands, including Kymriah (tisagenlecleucel): integral member of the team who led the registration (TGA) and reimbursement (MSAC) of the first CAR-T and cell therapies-based treatment in Australia- Regional Award for leading and implementing “Ways of Working”: integration of new ways of working into workplace behaviours; driving an open, empowering, transparent, and inspiring culture throughout the organisation- Early Access to Medicines: implementation of initiatives to streamline processes, driving savings and increasing the speed/number of request evaluation- “Courage Award”: partnering with several stakeholders to support registration and reimbursement submissions. Successful engagement with Health Authorities leading to positive outcomes for patients (equitable and sustainable access to medicines)

Sydney, Australia

Sydney, Australia

- Leading a team of 5 associates, Senior Medical Advisors and Senior Medical Scientific Liaisons- Supervision of the product development team for compounds in development (in preparation for product launch)- Support to the development of registration and reimbursement dossiers- Publication of two national consensus statements on Meylofibrosis, coinciding with the launch of Jakavi in Australia- Oversight of the publication of national guidelines on chronic myeloid leukaemia- “Courage Award”: for partnering with several stakeholders to support registration (TGA) and reimbursement (PBS) submissions- “Competitive intelligence” Award: translating science into marketing strategies for commercial use and improvement of patient outcomes- Two “On the spot Awards”: medical education weekend meetings – excellence in delivery of medical education- Two “On the spot awards”: Coach and Lead, and Excellence in organizing an Investigator Meeting to improve recruitment of patients to clinical trials

Sydney, Australia

- Medical education initiatives attended by several hundred medical experts, including international speakers and patient groups- Digital initiatives to deliver live and on-demand medical education across Australia and overseas, creating opportunities for exchange pre/during/post-events - Local support and management of pre-clinical/translational research, and phase I-IV clinical trials (global, local-sponsored, investigator-initiated, including Real World Evidence studies)- Planning and implementation of numerous local activities (e.g. national educational meetings, advisory boards, clinical studies, national treatment guidelines)- Development of concepts, protocols, and protocol amendments for clinical trials- Training and support of Product Specialists (including, but not limited to, training on utilizing new promotional materials, field visits and coaching, and objection handling workshops)- Collaboration with the marketing team to produce and implement promotional materials, including copy clearance- Publication of national treatment guidelines on the management of iron overload, and how to optimally treat patients with iron chelators- Support to the development of registration and reimbursement dossiers- Nomination for “Team award” Regional award. Medical education weekend meeting - Annual Award “External focus”. First prize. Nominations across both Oncology and General Medicines- 2011 Nomination for “Best teamwork”, Quarterly Award. For several activities developed with the marketing team

Phd, Cell/Cellular And Molecular Biology

Phd Training Programme, Cell/Cellular And Molecular Biology

Master Of Science (Msc) In Cell Biology, Cell Biology

Doctor Of Dental Surgery (Dds), Dentistry